Dr. Deborah Burshtyn – Associate Professor, MMI; Lead – Human Immunology @uAlberta
“Why MIGHT my post transplant patient HAVE GOTTEN CMV disease?” or “Polymorphism of the co-inhibtiory receptor LILRB1 targeted by a CMV immune evasion protein and post-transplant susceptibility to CMV reactivation.”

Infectious Diseases, Medical Microbiology and Immunology, and Li Ka Shing Institute
TRANSLATIONAL ROUNDS – all welcome!
With a clinical case presentation from Transplant Infectious Diseases UAH
11:00AM  CLASSROOM  (2F1.04)